ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis
Public ClinicalTrials.gov record NCT07011706. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ATI-045 in Patients With Moderate-to-Severe Atopic Dermatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study evaluates ATI-045 versus placebo in patients with Moderate-to-Severe Atopic Dermatitis.
Study identification
- NCT ID
- NCT07011706
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 110 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 30, 2025 (Actual)
- Primary completion
- Sep 21, 2026 (Actual)
- Completion
- Nov 24, 2026 (Estimated)
- Last update posted
- Sep 29, 2026
2025 – 2026
United States locations
- U.S. sites
- 53
- U.S. states
- 20
- U.S. cities
- 50
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Aclaris Clinical Site | Phoenix | Arizona | 85008 | — |
| Aclaris Clinical Site | Tucson | Arizona | 85704 | — |
| Aclaris Study Site | Bryant | Arkansas | 71913 | — |
| Aclaris Clinical Site | Beverly Hills | California | 90212 | — |
| Aclaris Study Site | Encinitas | California | 92024 | — |
| Aclaris Clinical Site | Encino | California | 91436 | — |
| Aclaris Clinical Site | Huntington Beach | California | 92647 | — |
| Aclaris Study Site | Los Angeles | California | 90045 | — |
| Aclaris Study Site | Oceanside | California | 92056 | — |
| Aclaris Study Site | Santa Monica | California | 90404 | — |
| Aclaris Clinical Site | Sherman Oaks | California | 91403 | — |
| Aclaris Clinical Site | Thousand Oaks | California | 91320 | — |
| Aclaris Study Site | Coral Gables | Florida | 33134 | — |
| Aclaris Clinical Site | Hollywood | Florida | 33486 | — |
| Aclaris Clinical Site | Jacksonville | Florida | 32256 | — |
| Aclaris Clinical Site | Margate | Florida | 33063 | — |
| Aclaris Study Site | North Miami Beach | Florida | 33162 | — |
| Aclaris Study Site | Sweetwater | Florida | 33172 | — |
| Aclaris Study Site | Tampa | Florida | 33607 | — |
| Aclaris Clinical Site | Wellington | Florida | 33449 | — |
| Aclaris Clinical Site | Atlanta | Georgia | 30315 | — |
| Aclaris Clinical Site | Savannah | Georgia | 31405 | — |
| Aclaris Study Site | Boise | Idaho | 83706 | — |
| Aclaris Study Site | Clarksville | Indiana | 47129 | — |
| Aclaris Study Site | Indianapolis | Indiana | 46250 | — |
| Aclaris Clinical Site | Lafayette | Indiana | 47906 | — |
| Aclaris Study Site | West Lafayette | Indiana | 47906 | — |
| Aclaris Study Site | Bowling Green | Kentucky | 42104 | — |
| Aclaris Clinical Site | Ann Arbor | Michigan | 48103 | — |
| Aclaris Study Site | Auburn Hills | Michigan | 48326 | — |
| Aclaris Clinical Site | Troy | Michigan | 48084 | — |
| Aclaris Clinical Site | Ridgeland | Mississippi | 39157 | — |
| Aclaris Study Site | Saint Joseph | Missouri | 64506 | — |
| Aclaris Clinical Site | Missoula | Montana | 59804 | — |
| Aclaris Study Site | New York | New York | 10023 | — |
| Aclaris Study Site | New York | New York | 10075 | — |
| Aclaris Clinical Site | New York | New York | 10128 | — |
| Aclaris Clinical Site | The Bronx | New York | 10455 | — |
| Aclaris Clinical Site | Cary | North Carolina | 27518 | — |
| Aclaris Clinical Site | Wilmington | North Carolina | 28405 | — |
| Aclaris Study Site | Camp Hill | Pennsylvania | 17011 | — |
| Aclaris Clinical Site | Philadelphia | Pennsylvania | 19103 | — |
| Aclaris Clinical Site | Myrtle Beach | South Carolina | 29588 | — |
| Aclaris Clinical Site | Dallas | Texas | 75230 | — |
| Aclaris Clinical Site | Houston | Texas | 77004 | — |
| Aclaris Study Site | San Antonio | Texas | 78213 | — |
| Aclaris Study Site | San Antonio | Texas | 78218 | — |
| Aclaris Clinical Site | The Woodlands | Texas | 77380 | — |
| Aclaris Study Site | Webster | Texas | 77598 | — |
| Aclaris Clinical Site | Providence | Utah | 84332 | — |
| Aclaris Study Site | Norfolk | Virginia | 23502 | — |
| Aclaris Clinical Site | Seattle | Washington | 98004 | — |
| Aclaris Clinical Site | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07011706, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 29, 2026 · Synced Oct 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07011706 live on ClinicalTrials.gov.